Sofia, Bulgaria, June 20, 2024 – According to the requirements of art. 100t of the Law on Public Offering of Sequrities (LPOS), “Sopharma” AD (SFA: “Bulgarian Stock Exchange” AD, SPH: Warsaw Stock Exchange) notifies that for May 2024 the Company recorded a decrease in sales of 20% compared to the same month of the previous year, incl. 14% decrease in domestic sales and 23% decrease in export sales.

From the beginning of 2024, the Company recorded a decrease in sales of 2%, incl. 6%  increase of domestic sales and 6% decrease in export sales.

Sofia, Bulgaria, June 18, 2024 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on June 17, 2024 the Company bought 1200 (one thousand two hundred) own shares representing 0.00067% of the share capital of the Company, at a total value of BGN 7 112,00 on the Bulgarian Stock Exchange, the average price per share was BGN 5,94.

Sofia, Bulgaria, June 17, 2024 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on June 13, 2024 the Company sold 49 984 (forty nine thousand nine hundred eighty four) repurchased own shares representing 0.027% of the share capital of the Company, at a total value of BGN 298 002,32 on the Bulgarian Stock Exchange, the average price per share was BGN 5,97.